NCT05769699 Serum Biomarkers in Parkinson's Disease at Different Stages
| NCT ID | NCT05769699 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Condition | Parkinson Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2022-02-10 |
| Primary Completion | 2023-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2022-02-10 with a primary completion date of 2023-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
* Determine clinical characteristics of parkinsonian patients in various stages of disease; * Measure peripheral neurodegeneration, synaptic, and inflammation biomarkers in a population of parkinsonian patients at various stages of disease. * Measure vesicular neurodegeneration, synaptic and inflammation biomarkers
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with idiopathic PD according to Movement Disorders Society (MDS) criteria; * Age: 18-80 years; * Signature of informed consent to participate in this study Exclusion criteria. * Women pregnant * Inflammatory or autoimmune diseases
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05769699 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05769699 currently recruiting?
Yes, NCT05769699 is actively recruiting participants. Contact the research team at giulia.dilazzaro@policlinicogemelli.it for enrollment information.
Where is the NCT05769699 trial being conducted?
This trial is being conducted at Roma, Italy.
Who is sponsoring the NCT05769699 clinical trial?
NCT05769699 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.